Association	O
between	O
ventricular	O
filling	O
patterns	O
and	O
the	O
extent	O
of	O
late	B:C0079595
enhancement	I:C0079595
on	O
magnetic	O
resonance	I:C0024485
imaging	I:C0024485
in	O
patients	O
with	O
hypertrophic	O
cardiomyopathy	I:C0007194
.	O

Association	O
between	O
ventricular	O
filling	O
patterns	O
and	O
the	O
extent	O
of	O
late	O
enhancement	I:C0079595
on	O
magnetic	B:C0024485
resonance	I:C0024485
imaging	I:C0024485
in	O
patients	O
with	O
hypertrophic	O
cardiomyopathy	I:C0007194
.	O

Association	O
between	O
ventricular	O
filling	O
patterns	O
and	O
the	O
extent	O
of	O
late	O
enhancement	I:C0079595
on	O
magnetic	O
resonance	I:C0024485
imaging	I:C0024485
in	O
patients	O
with	O
hypertrophic	B:C0007194
cardiomyopathy	I:C0007194
.	O

To	O
explore	O
the	O
relationship	O
between	O
ventricular	O
filling	O
curves	O
and	O
the	O
extent	O
of	O
late	B:C0079595
enhancement	I:C0079595
on	O
cardiac	O
magnetic	O
resonance	I:C0024485
imaging	I:C0024485
(	O
magnetic	O
resonance	I:C0024485
imaging	I:C0024485
)	O
in	O
patients	O
with	O
hypertrophic	O
cardiomyopathy	I:C0007194
.	O

To	O
explore	O
the	O
relationship	O
between	O
ventricular	O
filling	O
curves	O
and	O
the	O
extent	O
of	O
late	O
enhancement	I:C0079595
on	O
cardiac	B:C0018787
magnetic	O
resonance	I:C0024485
imaging	I:C0024485
(	O
magnetic	O
resonance	I:C0024485
imaging	I:C0024485
)	O
in	O
patients	O
with	O
hypertrophic	O
cardiomyopathy	I:C0007194
.	O

To	O
explore	O
the	O
relationship	O
between	O
ventricular	O
filling	O
curves	O
and	O
the	O
extent	O
of	O
late	O
enhancement	I:C0079595
on	O
cardiac	O
magnetic	B:C0024485
resonance	I:C0024485
imaging	I:C0024485
(	O
magnetic	O
resonance	I:C0024485
imaging	I:C0024485
)	O
in	O
patients	O
with	O
hypertrophic	O
cardiomyopathy	I:C0007194
.	O

To	O
explore	O
the	O
relationship	O
between	O
ventricular	O
filling	O
curves	O
and	O
the	O
extent	O
of	O
late	O
enhancement	I:C0079595
on	O
cardiac	O
magnetic	O
resonance	I:C0024485
imaging	I:C0024485
(	O
magnetic	B:C0024485
resonance	I:C0024485
imaging	I:C0024485
)	O
in	O
patients	O
with	O
hypertrophic	O
cardiomyopathy	I:C0007194
.	O

To	O
explore	O
the	O
relationship	O
between	O
ventricular	O
filling	O
curves	O
and	O
the	O
extent	O
of	O
late	O
enhancement	I:C0079595
on	O
cardiac	O
magnetic	O
resonance	I:C0024485
imaging	I:C0024485
(	O
magnetic	O
resonance	I:C0024485
imaging	I:C0024485
)	O
in	O
patients	O
with	O
hypertrophic	B:C0007194
cardiomyopathy	I:C0007194
.	O

We	O
retrospectively	O
included	O
consecutive	O
patients	O
with	O
suspected	O
and	O
/	O
or	O
confirmed	O
hypertrophic	B:C0007194
cardiomyopathy	I:C0007194
and	O
a	O
control	O
group	O
of	O
patients	O
matched	O
for	O
age	O
and	O
sex	O
who	O
underwent	O
cardiac	O
magnetic	O
resonance	I:C0024485
imaging	I:C0024485
with	O
evaluation	O
of	O
late	O
enhancement	I:C0079595
.	O

We	O
retrospectively	O
included	O
consecutive	O
patients	O
with	O
suspected	O
and	O
/	O
or	O
confirmed	O
hypertrophic	O
cardiomyopathy	I:C0007194
and	O
a	O
control	O
group	O
of	O
patients	O
matched	O
for	O
age	O
and	O
sex	O
who	O
underwent	O
cardiac	B:C0018787
magnetic	O
resonance	I:C0024485
imaging	I:C0024485
with	O
evaluation	O
of	O
late	O
enhancement	I:C0079595
.	O

We	O
retrospectively	O
included	O
consecutive	O
patients	O
with	O
suspected	O
and	O
/	O
or	O
confirmed	O
hypertrophic	O
cardiomyopathy	I:C0007194
and	O
a	O
control	O
group	O
of	O
patients	O
matched	O
for	O
age	O
and	O
sex	O
who	O
underwent	O
cardiac	O
magnetic	B:C0024485
resonance	I:C0024485
imaging	I:C0024485
with	O
evaluation	O
of	O
late	O
enhancement	I:C0079595
.	O

We	O
retrospectively	O
included	O
consecutive	O
patients	O
with	O
suspected	O
and	O
/	O
or	O
confirmed	O
hypertrophic	O
cardiomyopathy	I:C0007194
and	O
a	O
control	O
group	O
of	O
patients	O
matched	O
for	O
age	O
and	O
sex	O
who	O
underwent	O
cardiac	O
magnetic	O
resonance	I:C0024485
imaging	I:C0024485
with	O
evaluation	O
of	O
late	B:C0079595
enhancement	I:C0079595
.	O

Among	O
other	O
determinations	O
,	O
we	O
evaluated	O
the	O
following	O
parameters	B:C0449381
on	O
cine	O
sequences	O
:	O
peak	O
filling	O
rate	O
,	O
time	O
to	O
the	O
first	O
peak	O
filling	O
rate	O
,	O
and	O
filling	O
rate	O
normalized	O
to	O
the	O
filling	O
volume	O
.	O

Late	B:C0079595
enhancement	I:C0079595
was	O
observed	O
in	O
29	O
(	O
73	O
%	O
)	O
of	O
the	O
40	O
patients	O
with	O
hypertrophic	O
cardiomyopathy	I:C0007194
.	O

Late	O
enhancement	I:C0079595
was	O
observed	O
in	O
29	O
(	O
73	O
%	O
)	O
of	O
the	O
40	O
patients	O
with	O
hypertrophic	B:C0007194
cardiomyopathy	I:C0007194
.	O

The	O
normalized	O
peak	O
filling	O
rate	O
was	O
significantly	O
lower	O
in	O
patients	O
with	O
late	B:C0079595
enhancement	I:C0079595
(	O
4.9	O
±	O
1.6	O
in	O
those	O
with	O
hypertrophic	O
cardiomyopathy	I:C0007194
positive	O
for	O
late	O
enhancement	I:C0079595
vs.	O
5.8	O
±	O
2.2	O
in	O
those	O
with	O
hypertrophic	O
cardiomyopathy	I:C0007194
negative	O
for	O
late	O
enhancement	I:C0079595
vs.	O
6.3	O
±	O
1.5	O
in	O
controls	O
,	O
p	O
=	O
0.008	O
)	O
and	O
the	O
time	O
to	O
peak	O
filling	O
was	O
longer	O
in	O
patients	O
with	O
late	O
enhancement	I:C0079595
(	O
540.6	O
±	O
89.7	O
ms	O
vs.	O
505.5	O
±	O
99.3	O
ms	O
in	O
those	O
with	O
hypertrophic	O
cardiomyopathy	I:C0007194
negative	O
for	O
late	O
enhancement	I:C0079595
vs.	O
486.9	O
±	O
86.3	O
ms	O
in	O
controls	O
,	O
p	O
=	O
0.02	O
)	O
.	O

The	O
normalized	O
peak	O
filling	O
rate	O
was	O
significantly	O
lower	O
in	O
patients	O
with	O
late	O
enhancement	I:C0079595
(	O
4.9	O
±	O
1.6	O
in	O
those	O
with	O
hypertrophic	B:C0007194
cardiomyopathy	I:C0007194
positive	O
for	O
late	O
enhancement	I:C0079595
vs.	O
5.8	O
±	O
2.2	O
in	O
those	O
with	O
hypertrophic	O
cardiomyopathy	I:C0007194
negative	O
for	O
late	O
enhancement	I:C0079595
vs.	O
6.3	O
±	O
1.5	O
in	O
controls	O
,	O
p	O
=	O
0.008	O
)	O
and	O
the	O
time	O
to	O
peak	O
filling	O
was	O
longer	O
in	O
patients	O
with	O
late	O
enhancement	I:C0079595
(	O
540.6	O
±	O
89.7	O
ms	O
vs.	O
505.5	O
±	O
99.3	O
ms	O
in	O
those	O
with	O
hypertrophic	O
cardiomyopathy	I:C0007194
negative	O
for	O
late	O
enhancement	I:C0079595
vs.	O
486.9	O
±	O
86.3	O
ms	O
in	O
controls	O
,	O
p	O
=	O
0.02	O
)	O
.	O

The	O
normalized	O
peak	O
filling	O
rate	O
was	O
significantly	O
lower	O
in	O
patients	O
with	O
late	O
enhancement	I:C0079595
(	O
4.9	O
±	O
1.6	O
in	O
those	O
with	O
hypertrophic	O
cardiomyopathy	I:C0007194
positive	B:C1446409
for	O
late	O
enhancement	I:C0079595
vs.	O
5.8	O
±	O
2.2	O
in	O
those	O
with	O
hypertrophic	O
cardiomyopathy	I:C0007194
negative	O
for	O
late	O
enhancement	I:C0079595
vs.	O
6.3	O
±	O
1.5	O
in	O
controls	O
,	O
p	O
=	O
0.008	O
)	O
and	O
the	O
time	O
to	O
peak	O
filling	O
was	O
longer	O
in	O
patients	O
with	O
late	O
enhancement	I:C0079595
(	O
540.6	O
±	O
89.7	O
ms	O
vs.	O
505.5	O
±	O
99.3	O
ms	O
in	O
those	O
with	O
hypertrophic	O
cardiomyopathy	I:C0007194
negative	O
for	O
late	O
enhancement	I:C0079595
vs.	O
486.9	O
±	O
86.3	O
ms	O
in	O
controls	O
,	O
p	O
=	O
0.02	O
)	O
.	O

The	O
normalized	O
peak	O
filling	O
rate	O
was	O
significantly	O
lower	O
in	O
patients	O
with	O
late	O
enhancement	I:C0079595
(	O
4.9	O
±	O
1.6	O
in	O
those	O
with	O
hypertrophic	O
cardiomyopathy	I:C0007194
positive	O
for	O
late	B:C0079595
enhancement	I:C0079595
vs.	O
5.8	O
±	O
2.2	O
in	O
those	O
with	O
hypertrophic	O
cardiomyopathy	I:C0007194
negative	O
for	O
late	O
enhancement	I:C0079595
vs.	O
6.3	O
±	O
1.5	O
in	O
controls	O
,	O
p	O
=	O
0.008	O
)	O
and	O
the	O
time	O
to	O
peak	O
filling	O
was	O
longer	O
in	O
patients	O
with	O
late	O
enhancement	I:C0079595
(	O
540.6	O
±	O
89.7	O
ms	O
vs.	O
505.5	O
±	O
99.3	O
ms	O
in	O
those	O
with	O
hypertrophic	O
cardiomyopathy	I:C0007194
negative	O
for	O
late	O
enhancement	I:C0079595
vs.	O
486.9	O
±	O
86.3	O
ms	O
in	O
controls	O
,	O
p	O
=	O
0.02	O
)	O
.	O

The	O
normalized	O
peak	O
filling	O
rate	O
was	O
significantly	O
lower	O
in	O
patients	O
with	O
late	O
enhancement	I:C0079595
(	O
4.9	O
±	O
1.6	O
in	O
those	O
with	O
hypertrophic	O
cardiomyopathy	I:C0007194
positive	O
for	O
late	O
enhancement	I:C0079595
vs.	O
5.8	O
±	O
2.2	O
in	O
those	O
with	O
hypertrophic	B:C0007194
cardiomyopathy	I:C0007194
negative	O
for	O
late	O
enhancement	I:C0079595
vs.	O
6.3	O
±	O
1.5	O
in	O
controls	O
,	O
p	O
=	O
0.008	O
)	O
and	O
the	O
time	O
to	O
peak	O
filling	O
was	O
longer	O
in	O
patients	O
with	O
late	O
enhancement	I:C0079595
(	O
540.6	O
±	O
89.7	O
ms	O
vs.	O
505.5	O
±	O
99.3	O
ms	O
in	O
those	O
with	O
hypertrophic	O
cardiomyopathy	I:C0007194
negative	O
for	O
late	O
enhancement	I:C0079595
vs.	O
486.9	O
±	O
86.3	O
ms	O
in	O
controls	O
,	O
p	O
=	O
0.02	O
)	O
.	O

The	O
normalized	O
peak	O
filling	O
rate	O
was	O
significantly	O
lower	O
in	O
patients	O
with	O
late	O
enhancement	I:C0079595
(	O
4.9	O
±	O
1.6	O
in	O
those	O
with	O
hypertrophic	O
cardiomyopathy	I:C0007194
positive	O
for	O
late	O
enhancement	I:C0079595
vs.	O
5.8	O
±	O
2.2	O
in	O
those	O
with	O
hypertrophic	O
cardiomyopathy	I:C0007194
negative	B:C0205160
for	O
late	O
enhancement	I:C0079595
vs.	O
6.3	O
±	O
1.5	O
in	O
controls	O
,	O
p	O
=	O
0.008	O
)	O
and	O
the	O
time	O
to	O
peak	O
filling	O
was	O
longer	O
in	O
patients	O
with	O
late	O
enhancement	I:C0079595
(	O
540.6	O
±	O
89.7	O
ms	O
vs.	O
505.5	O
±	O
99.3	O
ms	O
in	O
those	O
with	O
hypertrophic	O
cardiomyopathy	I:C0007194
negative	O
for	O
late	O
enhancement	I:C0079595
vs.	O
486.9	O
±	O
86.3	O
ms	O
in	O
controls	O
,	O
p	O
=	O
0.02	O
)	O
.	O

The	O
normalized	O
peak	O
filling	O
rate	O
was	O
significantly	O
lower	O
in	O
patients	O
with	O
late	O
enhancement	I:C0079595
(	O
4.9	O
±	O
1.6	O
in	O
those	O
with	O
hypertrophic	O
cardiomyopathy	I:C0007194
positive	O
for	O
late	O
enhancement	I:C0079595
vs.	O
5.8	O
±	O
2.2	O
in	O
those	O
with	O
hypertrophic	O
cardiomyopathy	I:C0007194
negative	O
for	O
late	B:C0079595
enhancement	I:C0079595
vs.	O
6.3	O
±	O
1.5	O
in	O
controls	O
,	O
p	O
=	O
0.008	O
)	O
and	O
the	O
time	O
to	O
peak	O
filling	O
was	O
longer	O
in	O
patients	O
with	O
late	O
enhancement	I:C0079595
(	O
540.6	O
±	O
89.7	O
ms	O
vs.	O
505.5	O
±	O
99.3	O
ms	O
in	O
those	O
with	O
hypertrophic	O
cardiomyopathy	I:C0007194
negative	O
for	O
late	O
enhancement	I:C0079595
vs.	O
486.9	O
±	O
86.3	O
ms	O
in	O
controls	O
,	O
p	O
=	O
0.02	O
)	O
.	O

The	O
normalized	O
peak	O
filling	O
rate	O
was	O
significantly	O
lower	O
in	O
patients	O
with	O
late	O
enhancement	I:C0079595
(	O
4.9	O
±	O
1.6	O
in	O
those	O
with	O
hypertrophic	O
cardiomyopathy	I:C0007194
positive	O
for	O
late	O
enhancement	I:C0079595
vs.	O
5.8	O
±	O
2.2	O
in	O
those	O
with	O
hypertrophic	O
cardiomyopathy	I:C0007194
negative	O
for	O
late	O
enhancement	I:C0079595
vs.	O
6.3	O
±	O
1.5	O
in	O
controls	O
,	O
p	O
=	O
0.008	O
)	O
and	O
the	O
time	O
to	O
peak	O
filling	O
was	O
longer	O
in	O
patients	O
with	O
late	B:C0079595
enhancement	I:C0079595
(	O
540.6	O
±	O
89.7	O
ms	O
vs.	O
505.5	O
±	O
99.3	O
ms	O
in	O
those	O
with	O
hypertrophic	O
cardiomyopathy	I:C0007194
negative	O
for	O
late	O
enhancement	I:C0079595
vs.	O
486.9	O
±	O
86.3	O
ms	O
in	O
controls	O
,	O
p	O
=	O
0.02	O
)	O
.	O

The	O
normalized	O
peak	O
filling	O
rate	O
was	O
significantly	O
lower	O
in	O
patients	O
with	O
late	O
enhancement	I:C0079595
(	O
4.9	O
±	O
1.6	O
in	O
those	O
with	O
hypertrophic	O
cardiomyopathy	I:C0007194
positive	O
for	O
late	O
enhancement	I:C0079595
vs.	O
5.8	O
±	O
2.2	O
in	O
those	O
with	O
hypertrophic	O
cardiomyopathy	I:C0007194
negative	O
for	O
late	O
enhancement	I:C0079595
vs.	O
6.3	O
±	O
1.5	O
in	O
controls	O
,	O
p	O
=	O
0.008	O
)	O
and	O
the	O
time	O
to	O
peak	O
filling	O
was	O
longer	O
in	O
patients	O
with	O
late	O
enhancement	I:C0079595
(	O
540.6	O
±	O
89.7	O
ms	O
vs.	O
505.5	O
±	O
99.3	O
ms	O
in	O
those	O
with	O
hypertrophic	B:C0007194
cardiomyopathy	I:C0007194
negative	O
for	O
late	O
enhancement	I:C0079595
vs.	O
486.9	O
±	O
86.3	O
ms	O
in	O
controls	O
,	O
p	O
=	O
0.02	O
)	O
.	O

The	O
normalized	O
peak	O
filling	O
rate	O
was	O
significantly	O
lower	O
in	O
patients	O
with	O
late	O
enhancement	I:C0079595
(	O
4.9	O
±	O
1.6	O
in	O
those	O
with	O
hypertrophic	O
cardiomyopathy	I:C0007194
positive	O
for	O
late	O
enhancement	I:C0079595
vs.	O
5.8	O
±	O
2.2	O
in	O
those	O
with	O
hypertrophic	O
cardiomyopathy	I:C0007194
negative	O
for	O
late	O
enhancement	I:C0079595
vs.	O
6.3	O
±	O
1.5	O
in	O
controls	O
,	O
p	O
=	O
0.008	O
)	O
and	O
the	O
time	O
to	O
peak	O
filling	O
was	O
longer	O
in	O
patients	O
with	O
late	O
enhancement	I:C0079595
(	O
540.6	O
±	O
89.7	O
ms	O
vs.	O
505.5	O
±	O
99.3	O
ms	O
in	O
those	O
with	O
hypertrophic	O
cardiomyopathy	I:C0007194
negative	B:C0205160
for	O
late	O
enhancement	I:C0079595
vs.	O
486.9	O
±	O
86.3	O
ms	O
in	O
controls	O
,	O
p	O
=	O
0.02	O
)	O
.	O

The	O
normalized	O
peak	O
filling	O
rate	O
was	O
significantly	O
lower	O
in	O
patients	O
with	O
late	O
enhancement	I:C0079595
(	O
4.9	O
±	O
1.6	O
in	O
those	O
with	O
hypertrophic	O
cardiomyopathy	I:C0007194
positive	O
for	O
late	O
enhancement	I:C0079595
vs.	O
5.8	O
±	O
2.2	O
in	O
those	O
with	O
hypertrophic	O
cardiomyopathy	I:C0007194
negative	O
for	O
late	O
enhancement	I:C0079595
vs.	O
6.3	O
±	O
1.5	O
in	O
controls	O
,	O
p	O
=	O
0.008	O
)	O
and	O
the	O
time	O
to	O
peak	O
filling	O
was	O
longer	O
in	O
patients	O
with	O
late	O
enhancement	I:C0079595
(	O
540.6	O
±	O
89.7	O
ms	O
vs.	O
505.5	O
±	O
99.3	O
ms	O
in	O
those	O
with	O
hypertrophic	O
cardiomyopathy	I:C0007194
negative	O
for	O
late	B:C0079595
enhancement	I:C0079595
vs.	O
486.9	O
±	O
86.3	O
ms	O
in	O
controls	O
,	O
p	O
=	O
0.02	O
)	O
.	O

When	O
the	O
population	B:C1257890
was	O
stratified	O
into	O
three	O
groups	O
in	O
function	O
of	O
the	O
normalized	O
peak	O
filling	O
rate	O
,	O
significant	O
differences	O
were	O
observed	O
among	O
groups	O
for	O
age	O
(	O
p	O
=	O
0.002	O
)	O
,	O
mean	O
wall	O
thickness	O
(	O
p	O
=	O
0.036	O
)	O
,	O
and	O
myocardial	O
mass	O
(	O
p	O
=	O
0.046	O
)	O
and	O
atrial	O
dimensions	O
,	O
whereas	O
no	O
significant	O
differences	O
with	O
respect	O
to	O
late	O
enhancement	I:C0079595
were	O
seen	O
.	O

When	O
the	O
population	O
was	O
stratified	O
into	O
three	O
groups	O
in	O
function	O
of	O
the	O
normalized	O
peak	O
filling	O
rate	O
,	O
significant	O
differences	O
were	O
observed	O
among	O
groups	O
for	O
age	O
(	O
p	O
=	O
0.002	O
)	O
,	O
mean	O
wall	O
thickness	O
(	O
p	O
=	O
0.036	O
)	O
,	O
and	O
myocardial	O
mass	O
(	O
p	O
=	O
0.046	O
)	O
and	O
atrial	O
dimensions	O
,	O
whereas	O
no	O
significant	O
differences	O
with	O
respect	O
to	O
late	B:C0079595
enhancement	I:C0079595
were	O
seen	O
.	O

In	O
patients	O
with	O
hypertrophic	B:C0007194
cardiomyopathy	I:C0007194
,	O
we	O
found	O
a	O
significant	O
association	O
between	O
ventricular	O
filling	O
patterns	O
and	O
age	O
,	O
wall	O
thicknesses	O
,	O
and	O
atrial	O
dimensions	O
,	O
but	O
not	O
with	O
the	O
extent	O
of	O
late	O
enhancement	I:C0079595
.	O

In	O
patients	O
with	O
hypertrophic	O
cardiomyopathy	I:C0007194
,	O
we	O
found	O
a	O
significant	O
association	O
between	O
ventricular	O
filling	O
patterns	O
and	O
age	O
,	O
wall	O
thicknesses	O
,	O
and	O
atrial	O
dimensions	O
,	O
but	O
not	O
with	O
the	O
extent	O
of	O
late	B:C0079595
enhancement	I:C0079595
.	O

